Robert Coffin
Founder at REPLIMUNE GROUP, INC.
Net worth: 11 M $ as of 2024-04-29
Robert Coffin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| REPLIMUNE GROUP, INC. | Director/Board Member | 2015-02-28 | - |
| Chief Tech/Sci/R&D Officer | - | - | |
| Founder | 2015-02-28 | - | |
| Chief Executive Officer | 2015-02-28 | 2020-01-08 | |
| President | 2015-02-28 | 2024-03-31 |
Career history of Robert Coffin
Former positions of Robert Coffin
| Companies | Position | Start | End |
|---|---|---|---|
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Director/Board Member | 1998-12-31 | 2013-01-23 |
| Chief Tech/Sci/R&D Officer | 1998-12-31 | 2013-01-23 | |
| Founder | 2009-10-14 | 2013-01-23 | |
| AMGEN INC. | Corporate Officer/Principal | 2010-12-31 | 2012-12-31 |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 1998-12-31 | 2011-03-03 |
| Chief Tech/Sci/R&D Officer | 1998-12-31 | 2011-03-03 | |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Director/Board Member | 1998-12-31 | - |
| Chief Tech/Sci/R&D Officer | 1998-12-31 | - | |
| Founder | 1998-12-31 | - |
Training of Robert Coffin
| Imperial College London | Doctorate Degree |
Statistics
International
| United States | 5 |
| United Kingdom | 3 |
Operational
| Director/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 3 |
Sectoral
| Health Technology | 5 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| REPLIMUNE GROUP, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 3 |
|---|---|
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
- Stock Market
- Insiders
- Robert Coffin
- Experience
